Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for ZNF711_TFAP2A_TFAP2D
Z-value: 2.70
Motif logo
Transcription factors associated with ZNF711_TFAP2A_TFAP2D
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF711
|
ENSG00000147180.17 | zinc finger protein 711 |
|
TFAP2A
|
ENSG00000137203.15 | transcription factor AP-2 alpha |
|
TFAP2D
|
ENSG00000008197.5 | transcription factor AP-2 delta |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TFAP2A | hg38_v1_chr6_-_10419638_10419665 | 0.35 | 5.1e-02 | Click! |
| ZNF711 | hg38_v1_chrX_+_85244075_85244121 | -0.02 | 9.3e-01 | Click! |
Activity profile of ZNF711_TFAP2A_TFAP2D motif
Sorted Z-values of ZNF711_TFAP2A_TFAP2D motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF711_TFAP2A_TFAP2D
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 18.3 | GO:0030421 | defecation(GO:0030421) |
| 2.6 | 7.8 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 2.5 | 7.5 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 2.3 | 20.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 2.0 | 16.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 1.9 | 9.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.9 | 1.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 1.9 | 7.5 | GO:0044691 | tooth eruption(GO:0044691) |
| 1.9 | 9.3 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 1.8 | 1.8 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 1.8 | 7.0 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.7 | 5.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.7 | 6.9 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 1.7 | 5.1 | GO:0031104 | dendrite regeneration(GO:0031104) |
| 1.7 | 6.7 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.7 | 8.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.7 | 6.6 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 1.6 | 8.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 1.6 | 1.6 | GO:0097017 | renal protein absorption(GO:0097017) |
| 1.6 | 4.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.6 | 3.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 1.5 | 6.2 | GO:1900163 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 1.5 | 9.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.5 | 5.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 1.5 | 4.4 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 1.5 | 4.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 1.5 | 4.4 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 1.5 | 4.4 | GO:0009386 | translational attenuation(GO:0009386) |
| 1.4 | 4.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.4 | 12.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.4 | 4.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 1.4 | 1.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 1.4 | 4.2 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 1.4 | 8.4 | GO:0015862 | uridine transport(GO:0015862) |
| 1.3 | 22.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 1.3 | 9.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.3 | 1.3 | GO:0060157 | urinary bladder development(GO:0060157) |
| 1.3 | 5.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 1.3 | 1.3 | GO:0051695 | actin filament uncapping(GO:0051695) |
| 1.3 | 5.2 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 1.3 | 5.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.3 | 6.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.3 | 3.8 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 1.3 | 20.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 1.2 | 9.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.2 | 3.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 1.2 | 4.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.2 | 7.4 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 1.2 | 6.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 1.2 | 3.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 1.2 | 4.9 | GO:0032600 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 1.2 | 9.7 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 1.2 | 4.8 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 1.2 | 3.6 | GO:0035445 | borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 1.2 | 6.0 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 1.2 | 33.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 1.2 | 1.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 1.1 | 3.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 1.1 | 3.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 1.1 | 6.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 1.1 | 7.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 1.1 | 4.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.1 | 6.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.1 | 4.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.1 | 7.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.1 | 5.3 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 1.1 | 2.1 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.1 | 6.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 1.1 | 12.7 | GO:0015705 | iodide transport(GO:0015705) |
| 1.1 | 4.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.0 | 1.0 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 1.0 | 7.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.0 | 2.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 1.0 | 3.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 1.0 | 4.1 | GO:0052360 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 1.0 | 3.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 1.0 | 1.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 1.0 | 4.1 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 1.0 | 6.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.0 | 5.0 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 1.0 | 5.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.0 | 3.9 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
| 1.0 | 3.9 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.0 | 3.9 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 1.0 | 7.8 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.0 | 1.0 | GO:1900450 | negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
| 1.0 | 2.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.0 | 3.9 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.0 | 4.8 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.0 | 3.8 | GO:0018277 | protein deamination(GO:0018277) |
| 1.0 | 2.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 1.0 | 1.9 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 1.0 | 2.9 | GO:0061011 | hepatic duct development(GO:0061011) |
| 1.0 | 2.9 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 1.0 | 6.7 | GO:0003383 | apical constriction(GO:0003383) |
| 1.0 | 1.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.9 | 2.8 | GO:0060733 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.9 | 4.7 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.9 | 0.9 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.9 | 2.8 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.9 | 2.8 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.9 | 7.4 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.9 | 8.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.9 | 4.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.9 | 4.6 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.9 | 7.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.9 | 4.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.9 | 2.7 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.9 | 3.6 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.9 | 5.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.9 | 5.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.9 | 5.4 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
| 0.9 | 0.9 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.9 | 4.5 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 0.9 | 4.4 | GO:0030806 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) |
| 0.9 | 0.9 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.9 | 2.7 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.9 | 2.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.9 | 5.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.9 | 5.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
| 0.9 | 0.9 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.9 | 0.9 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.9 | 8.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.9 | 0.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.9 | 3.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
| 0.9 | 3.4 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.9 | 2.6 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.9 | 8.5 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.9 | 3.4 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.8 | 4.2 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.8 | 2.5 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 | 3.3 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.8 | 2.5 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 0.8 | 3.3 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.8 | 3.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.8 | 2.5 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.8 | 4.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.8 | 2.4 | GO:0097086 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.8 | 1.6 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.8 | 20.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.8 | 2.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.8 | 2.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.8 | 0.8 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
| 0.8 | 4.0 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.8 | 2.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.8 | 1.6 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
| 0.8 | 2.3 | GO:0061445 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell differentiation(GO:0061443) endocardial cushion cell fate commitment(GO:0061445) |
| 0.8 | 3.1 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.8 | 3.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.8 | 2.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.8 | 10.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.8 | 3.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.8 | 2.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.8 | 3.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 | 13.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.8 | 3.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.8 | 3.0 | GO:0003290 | atrial septum secundum morphogenesis(GO:0003290) |
| 0.8 | 1.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.7 | 2.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.7 | 4.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.7 | 2.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.7 | 0.7 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.7 | 4.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 | 4.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 | 2.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.7 | 3.6 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 0.7 | 8.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.7 | 55.9 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.7 | 2.1 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.7 | 2.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.7 | 2.1 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.7 | 4.2 | GO:0008354 | germ cell migration(GO:0008354) |
| 0.7 | 4.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.7 | 0.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.7 | 2.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.7 | 4.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
| 0.7 | 7.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.7 | 3.5 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 0.7 | 5.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
| 0.7 | 5.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.7 | 2.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.7 | 4.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.7 | 4.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.7 | 2.8 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.7 | 2.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.7 | 2.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.7 | 4.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.7 | 8.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.7 | 1.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.7 | 1.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.7 | 0.7 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
| 0.7 | 4.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.7 | 5.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.7 | 2.0 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.7 | 2.0 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.7 | 2.7 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.7 | 0.7 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.7 | 2.0 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.7 | 2.0 | GO:0060936 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.7 | 1.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.7 | 10.0 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.7 | 2.7 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
| 0.7 | 2.6 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.7 | 3.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.7 | 2.6 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.7 | 2.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.7 | 4.6 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.7 | 3.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.7 | 3.9 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.7 | 7.2 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.6 | 1.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.6 | 7.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.6 | 2.6 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 0.6 | 1.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.6 | 4.5 | GO:1901377 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.6 | 2.6 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.6 | 3.8 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.6 | 6.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.6 | 4.5 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.6 | 28.7 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.6 | 2.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.6 | 1.9 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.6 | 3.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.6 | 1.3 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
| 0.6 | 1.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 | 3.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.6 | 1.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.6 | 6.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.6 | 2.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.6 | 1.9 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.6 | 3.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.6 | 1.9 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.6 | 6.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.6 | 1.9 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 0.6 | 3.1 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.6 | 2.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.6 | 1.8 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.6 | 0.6 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.6 | 2.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.6 | 0.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.6 | 1.8 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.6 | 1.8 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.6 | 3.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.6 | 3.6 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
| 0.6 | 3.0 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.6 | 0.6 | GO:0071035 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.6 | 4.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.6 | 1.8 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.6 | 0.6 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.6 | 3.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.6 | 3.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.6 | 0.6 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.6 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.6 | 3.5 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.6 | 3.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.6 | 1.2 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.6 | 2.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.6 | 0.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.6 | 1.1 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.6 | 2.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.6 | 4.0 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.6 | 1.7 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.6 | 4.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.6 | 3.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.6 | 2.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.6 | 2.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.6 | 1.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.6 | 3.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.6 | 5.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.6 | 1.7 | GO:1903988 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.6 | 20.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.6 | 2.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.6 | 5.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.6 | 1.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.6 | 5.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.6 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.6 | 0.6 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.6 | 1.7 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.6 | 1.7 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.6 | 1.1 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.6 | 8.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.5 | 1.6 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.5 | 1.1 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.5 | 3.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.5 | 4.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 | 3.3 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.5 | 2.2 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
| 0.5 | 1.6 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.5 | 1.6 | GO:0035732 | nitric oxide storage(GO:0035732) |
| 0.5 | 3.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.5 | 3.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.5 | 0.5 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.5 | 2.7 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.5 | 2.7 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.5 | 2.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.5 | 4.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.5 | 2.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.5 | 5.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.5 | 1.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.5 | 6.9 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.5 | 0.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.5 | 3.2 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.5 | 3.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 | 8.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.5 | 2.6 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.5 | 1.6 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.5 | 3.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.5 | 1.6 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.5 | 2.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 | 3.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
| 0.5 | 3.7 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.5 | 4.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.5 | 1.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.5 | 6.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.5 | 1.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.5 | 7.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.5 | 7.8 | GO:0015074 | DNA integration(GO:0015074) |
| 0.5 | 1.6 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.5 | 1.6 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.5 | 5.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.5 | 3.6 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.5 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.5 | 9.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.5 | 3.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.5 | 6.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 2.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.5 | 3.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.5 | 7.7 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.5 | 3.1 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.5 | 2.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.5 | 0.5 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.5 | 0.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.5 | 0.5 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.5 | 0.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.5 | 3.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.5 | 0.5 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.5 | 6.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.5 | 1.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.5 | 5.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.5 | 3.0 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.5 | 2.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 | 3.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.5 | 6.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.5 | 1.0 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.5 | 0.5 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.5 | 0.5 | GO:0014854 | response to inactivity(GO:0014854) |
| 0.5 | 1.5 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.5 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.5 | 3.0 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.5 | 1.0 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.5 | 0.5 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.5 | 3.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.5 | 2.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.5 | 2.9 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.5 | 6.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.5 | 1.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.5 | 1.5 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
| 0.5 | 1.5 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.5 | 0.5 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.5 | 0.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.5 | 2.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 3.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.5 | 1.4 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.5 | 8.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.5 | 3.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.5 | 2.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.5 | 1.4 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.5 | 3.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.5 | 1.0 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.5 | 2.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.5 | 4.7 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.5 | 8.1 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.5 | 2.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.5 | 1.4 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.5 | 1.9 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
| 0.5 | 2.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.5 | 3.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.5 | 1.9 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
| 0.5 | 6.1 | GO:0030091 | protein repair(GO:0030091) |
| 0.5 | 3.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.5 | 1.9 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.5 | 1.8 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.5 | 5.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.5 | 6.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.5 | 4.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.5 | 11.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.5 | 1.8 | GO:0033590 | response to cobalamin(GO:0033590) |
| 0.5 | 0.9 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
| 0.5 | 0.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.5 | 2.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.5 | 1.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.5 | 1.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 | 4.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.5 | 1.4 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.5 | 4.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.5 | 1.8 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.5 | 2.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.5 | 1.8 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.5 | 7.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.5 | 1.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.4 | 4.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
| 0.4 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.4 | 2.2 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.4 | 5.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.4 | 1.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.4 | 2.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.4 | 2.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 1.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.4 | 1.3 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.4 | 0.4 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.4 | 2.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 | 0.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.4 | 3.1 | GO:0060356 | leucine import(GO:0060356) |
| 0.4 | 1.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.4 | 1.8 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.4 | 2.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.4 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 | 2.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 | 11.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.4 | 0.9 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.4 | 0.4 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.4 | 6.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.4 | 3.4 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.4 | 8.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.4 | 1.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.4 | 3.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.4 | 8.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.4 | 1.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.4 | 1.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.4 | 1.3 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.4 | 0.4 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) positive regulation of protein localization to cilium(GO:1903566) |
| 0.4 | 2.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.4 | 0.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.4 | 3.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.4 | 9.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 | 0.8 | GO:0052510 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.4 | 0.8 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.4 | 2.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.4 | 2.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.4 | 1.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.4 | 0.4 | GO:0033151 | V(D)J recombination(GO:0033151) |
| 0.4 | 0.4 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.4 | 1.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.4 | 1.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.4 | 6.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.4 | 0.8 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.4 | 0.4 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 | 8.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.4 | 2.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.4 | 1.2 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.4 | 1.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.4 | 1.2 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.4 | 1.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.4 | 0.4 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.4 | 1.6 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.4 | 2.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.4 | 1.2 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
| 0.4 | 2.5 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.4 | 3.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.4 | 3.3 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.4 | 0.4 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.4 | 2.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.4 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.4 | 1.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
| 0.4 | 2.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.4 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.4 | 5.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.4 | 17.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.4 | 2.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.4 | 3.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.4 | 3.2 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.4 | 1.2 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.4 | 0.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 | 5.6 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.4 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.4 | 0.8 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.4 | 1.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.4 | 2.8 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 | 0.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.4 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.4 | 4.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.4 | 3.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.4 | 2.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.4 | 0.4 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.4 | 4.0 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.4 | 7.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
| 0.4 | 2.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.4 | 1.6 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 | 2.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 | 2.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.4 | 5.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.4 | 1.6 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
| 0.4 | 0.4 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
| 0.4 | 7.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.4 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.4 | 6.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.4 | 13.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.4 | 3.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 1.2 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 0.4 | 0.8 | GO:0018963 | phthalate metabolic process(GO:0018963) |
| 0.4 | 1.5 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.4 | 10.4 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
| 0.4 | 0.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 | 1.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.4 | 1.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.4 | 1.5 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.4 | 2.3 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.4 | 1.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.4 | 0.8 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.4 | 2.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.4 | 1.1 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.4 | 1.1 | GO:1904863 | regulation of beta-catenin-TCF complex assembly(GO:1904863) negative regulation of beta-catenin-TCF complex assembly(GO:1904864) |
| 0.4 | 1.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.4 | 1.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.4 | 1.1 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.4 | 0.4 | GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.4 | 9.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.4 | 1.5 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.4 | 3.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.4 | 7.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.4 | 2.3 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.4 | 0.8 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.4 | 1.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 | 0.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.4 | 1.5 | GO:0048627 | myoblast development(GO:0048627) |
| 0.4 | 5.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.4 | 2.6 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.4 | 1.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.4 | 8.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.4 | 1.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.4 | 2.2 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.4 | 0.7 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.4 | 2.6 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.4 | 1.8 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.4 | 3.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.4 | 4.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 1.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.4 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.4 | 1.5 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.4 | 1.8 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.4 | 0.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.4 | 0.7 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.4 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.4 | 4.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.4 | 2.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.4 | 3.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 | 10.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.4 | 0.4 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.4 | 2.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.4 | 0.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.4 | 1.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.4 | 0.7 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.4 | 0.4 | GO:0060435 | bronchiole development(GO:0060435) |
| 0.4 | 2.2 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.4 | 1.4 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 | 1.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.4 | 6.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.4 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.4 | 1.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.4 | 1.1 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.4 | 0.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.4 | 4.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.4 | 0.7 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.4 | 1.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.4 | 1.1 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.4 | 1.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.4 | 1.4 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.4 | 1.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 1.8 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.4 | 2.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.4 | 2.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.4 | 0.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.3 | 3.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.3 | 1.7 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.3 | 3.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.3 | 0.3 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.3 | 9.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.3 | 1.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 | 2.8 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.3 | 3.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.3 | 3.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 | 1.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.3 | 1.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.3 | 7.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.3 | 0.3 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.3 | 1.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.3 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 | 1.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 | 1.4 | GO:0007140 | male meiosis(GO:0007140) |
| 0.3 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
| 0.3 | 2.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.3 | 5.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 | 1.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.3 | 2.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 1.4 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.3 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.3 | 1.0 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.3 | 0.3 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.3 | 1.3 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.3 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.3 | 2.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 1.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.3 | 1.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 0.7 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 0.3 | 0.7 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.3 | 2.0 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 | 2.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.3 | 0.3 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.3 | 1.6 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.3 | 2.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 | 3.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.3 | 3.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
| 0.3 | 1.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.3 | 1.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 | 2.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 1.3 | GO:0009631 | cold acclimation(GO:0009631) |
| 0.3 | 1.3 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.3 | 1.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.3 | 1.0 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.3 | 5.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.3 | 2.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.3 | 2.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.3 | 0.3 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.3 | 0.6 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.3 | 2.6 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.3 | 1.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 | 1.6 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.3 | 0.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.3 | 3.2 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.3 | 0.6 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.3 | 4.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 | 1.3 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.3 | 6.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 | 4.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.3 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
| 0.3 | 1.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 3.2 | GO:0060065 | uterus development(GO:0060065) |
| 0.3 | 18.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.3 | 0.6 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.3 | 1.6 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.3 | 5.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 0.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.3 | 3.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 4.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.3 | 6.0 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.3 | 10.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 0.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.3 | 1.2 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.3 | 21.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.3 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.3 | 1.5 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.3 | 0.9 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.3 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 | 1.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.3 | 0.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.3 | 0.6 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.3 | 0.9 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.3 | 0.9 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 | 2.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 | 2.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.3 | 0.9 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 0.3 | 3.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.3 | 0.9 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.3 | 3.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.3 | 4.8 | GO:0042407 | cristae formation(GO:0042407) |
| 0.3 | 0.6 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.3 | 1.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.3 | 0.9 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.3 | 1.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.3 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
| 0.3 | 0.3 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.3 | 2.7 | GO:0072189 | ureter development(GO:0072189) |
| 0.3 | 0.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.3 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.3 | 3.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 2.4 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.3 | 2.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.3 | 2.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.3 | 1.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.3 | 1.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) response to methylglyoxal(GO:0051595) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.3 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 | 1.8 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.3 | 2.1 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.3 | 7.6 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.3 | 4.7 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.3 | 2.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 | 7.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 | 0.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.3 | 7.6 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 | 1.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.3 | 1.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.3 | 1.7 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.3 | 0.3 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.3 | 1.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 | 8.7 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.3 | 1.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.3 | 16.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.3 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.3 | 0.9 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.3 | 2.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.3 | 3.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.3 | 1.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.3 | 3.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.3 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 1.1 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.3 | 16.0 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.3 | 2.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.3 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.3 | 4.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.3 | 2.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.3 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.3 | 1.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.3 | 1.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
| 0.3 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.3 | 0.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.3 | 0.6 | GO:1903004 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 0.3 | 1.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.3 | 0.8 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.3 | 3.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.3 | 1.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 | 1.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.3 | 1.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.3 | 3.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 | 2.5 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.3 | 3.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 | 2.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.3 | 1.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.3 | 4.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.3 | 1.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.3 | 4.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.3 | 7.4 | GO:0038202 | TORC1 signaling(GO:0038202) |
| 0.3 | 4.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.3 | 1.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.3 | 1.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.3 | 2.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.3 | 0.8 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.3 | 0.8 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.3 | 1.3 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.3 | 1.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.3 | 0.3 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.3 | 0.5 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.3 | 0.5 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
| 0.3 | 0.5 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.3 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.3 | 11.8 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.3 | 1.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.3 | 0.8 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 2.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 | 14.4 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.3 | 2.4 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.3 | 0.5 | GO:0060003 | copper ion export(GO:0060003) |
| 0.3 | 3.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 0.3 | 1.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 1.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.3 | 3.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 | 0.5 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.3 | 3.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.3 | 1.3 | GO:0036233 | glycine import(GO:0036233) |
| 0.3 | 1.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.3 | 2.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.3 | 2.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 | 1.0 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.3 | 4.7 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.3 | 1.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.3 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.3 | 2.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 0.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.3 | 0.8 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.3 | 0.8 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) |
| 0.3 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 | 3.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.3 | 2.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.3 | 3.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.3 | 1.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.3 | 1.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.3 | 1.3 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.3 | 5.7 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.3 | 1.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.3 | 1.5 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.3 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.3 | 5.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 2.6 | GO:0072338 | cellular lactam metabolic process(GO:0072338) |
| 0.3 | 1.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.3 | 0.3 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
| 0.3 | 0.3 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.3 | 3.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.3 | 1.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.3 | 2.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.3 | 0.5 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.3 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 | 1.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.3 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 | 0.8 | GO:2000773 | negative regulation of cell aging(GO:0090344) negative regulation of cellular senescence(GO:2000773) |
| 0.3 | 2.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 | 0.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 4.0 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.3 | 4.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.2 | 0.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.2 | 7.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.2 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.2 | 5.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.2 | 5.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 0.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 | 1.5 | GO:0015677 | copper ion import(GO:0015677) |
| 0.2 | 8.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.2 | 1.7 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.2 | 2.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.2 | 1.0 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
| 0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 1.2 | GO:0044650 | adhesion of symbiont to host cell(GO:0044650) |
| 0.2 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 2.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 | 1.0 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 1.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 0.2 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.2 | 1.9 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.2 | 3.4 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 0.2 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 0.2 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.2 | 1.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 2.9 | GO:0043586 | tongue development(GO:0043586) |
| 0.2 | 1.2 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.2 | 3.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 1.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 | 0.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.2 | 0.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 | 1.7 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 1.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.2 | 3.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 1.2 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.2 | 0.7 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.2 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 | 2.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 | 0.9 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 0.5 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.2 | 2.6 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.2 | 2.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 | 0.7 | GO:0030682 | evasion or tolerance of host immune response(GO:0020012) evasion or tolerance of host defense response(GO:0030682) evasion or tolerance by virus of host immune response(GO:0030683) evasion or tolerance of immune response of other organism involved in symbiotic interaction(GO:0051805) evasion or tolerance of defense response of other organism involved in symbiotic interaction(GO:0051807) |
| 0.2 | 3.8 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.2 | 0.5 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.2 | 0.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 | 0.5 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.2 | 0.9 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
| 0.2 | 0.2 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
| 0.2 | 4.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.2 | 0.5 | GO:0014889 | muscle atrophy(GO:0014889) |
| 0.2 | 1.6 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 | 1.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.2 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
| 0.2 | 1.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.2 | 1.1 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.2 | 0.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) glucosamine catabolic process(GO:0006043) |
| 0.2 | 2.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 | 1.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 | 1.6 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.2 | 0.9 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.2 | 2.7 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.2 | 1.8 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 5.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.2 | 1.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 2.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 | 0.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 | 0.5 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 | 2.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.2 | 0.4 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.2 | 0.7 | GO:0098504 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
| 0.2 | 8.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 | 2.5 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 | 0.4 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.2 | 1.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.2 | 3.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.2 | 1.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.2 | 2.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 | 2.0 | GO:0007135 | meiosis II(GO:0007135) |
| 0.2 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 | 2.9 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.2 | 1.1 | GO:0035934 | corticosterone secretion(GO:0035934) |
| 0.2 | 0.4 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.2 | 1.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 1.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 | 2.9 | GO:0015747 | urate transport(GO:0015747) |
| 0.2 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 | 1.1 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.2 | 0.7 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.2 | 2.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 2.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 2.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.2 | 1.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 | 0.7 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 | 0.9 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 | 2.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 1.9 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 | 1.1 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
| 0.2 | 2.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.2 | 0.9 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.2 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 | 1.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 | 2.4 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.2 | 4.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.2 | 3.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 4.7 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.2 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.2 | 2.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.2 | 4.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.2 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.2 | 0.8 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) |
| 0.2 | 2.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 3.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.2 | 5.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.2 | 1.5 | GO:0097468 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) |
| 0.2 | 0.8 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.2 | 1.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.2 | 24.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.2 | 2.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.2 | 1.0 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.2 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.2 | 1.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.2 | 3.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 | 7.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.2 | 5.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 0.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.2 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.2 | 1.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.2 | 0.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.2 | 0.6 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.2 | 0.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
| 0.2 | 0.8 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.2 | 2.9 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.2 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 | 0.6 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.2 | 2.1 | GO:0003360 | brainstem development(GO:0003360) |
| 0.2 | 0.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.2 | 3.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 | 2.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 3.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.2 | 0.8 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 1.6 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.2 | 3.9 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
| 0.2 | 8.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 | 0.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.2 | 0.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 0.6 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.2 | 2.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.2 | 0.2 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 2.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.2 | 1.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.2 | 0.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 | 1.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 | 0.6 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 | 2.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 0.4 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 0.6 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.2 | 1.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 0.6 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 | 0.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.2 | 0.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.2 | 4.6 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.2 | 0.6 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.2 | 5.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.2 | 0.4 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
| 0.2 | 1.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 | 6.7 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 | 2.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 | 2.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.2 | 0.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
| 0.2 | 11.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 1.2 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 2.5 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.2 | 5.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.2 | 0.2 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.2 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.2 | 0.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 | 0.8 | GO:0071864 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.2 | 0.2 | GO:0060977 | coronary vasculature morphogenesis(GO:0060977) |
| 0.2 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.2 | 0.8 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.2 | 1.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
| 0.2 | 0.2 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.2 | 2.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 1.9 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.2 | 10.5 | GO:0043297 | apical junction assembly(GO:0043297) |
| 0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 1.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 | 0.4 | GO:0048320 | axial mesoderm morphogenesis(GO:0048319) axial mesoderm formation(GO:0048320) |
| 0.2 | 1.3 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.2 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) response to rapamycin(GO:1901355) |
| 0.2 | 4.3 | GO:0043489 | RNA stabilization(GO:0043489) |
| 0.2 | 3.7 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.2 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 1.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 | 0.6 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.2 | 2.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 0.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.2 | 18.9 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
| 0.2 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.2 | 10.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.2 | 0.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
| 0.2 | 0.9 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.2 | 0.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.2 | 0.4 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.2 | 4.6 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.2 | 2.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 1.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 | 0.2 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.2 | 0.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
| 0.2 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 | 0.2 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.2 | 1.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.2 | 1.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 2.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 | 0.2 | GO:0071812 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.2 | 1.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.2 | 0.2 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) |
| 0.2 | 1.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.2 | 9.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.2 | 4.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 | 5.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.2 | 1.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 | 0.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.2 | 0.5 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.2 | 34.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.2 | 1.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.2 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.2 | 0.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.2 | 0.7 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.2 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 5.2 | GO:0071514 | genetic imprinting(GO:0071514) |
| 0.2 | 1.0 | GO:0009650 | UV protection(GO:0009650) |
| 0.2 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.3 | GO:0046356 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
| 0.2 | 1.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.2 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.2 | 2.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.2 | 1.0 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 0.7 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.2 | 1.0 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.2 | 1.7 | GO:0071174 | mitotic spindle checkpoint(GO:0071174) |
| 0.2 | 1.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.2 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 2.2 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
| 0.2 | 0.3 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
| 0.2 | 6.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.2 | 1.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.2 | 1.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.2 | 0.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 | 0.5 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
| 0.2 | 0.3 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.2 | 0.8 | GO:0007530 | sex determination(GO:0007530) |
| 0.2 | 2.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
| 0.2 | 20.8 | GO:0006415 | translational termination(GO:0006415) |
| 0.2 | 2.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.2 | 0.2 | GO:0048382 | mesendoderm development(GO:0048382) |
| 0.2 | 1.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 0.2 | 1.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 3.8 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.2 | 1.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.2 | 0.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
| 0.2 | 0.5 | GO:0006463 | steroid hormone receptor complex assembly(GO:0006463) |
| 0.2 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.2 | 1.0 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.2 | 2.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.2 | 1.6 | GO:0051775 | response to redox state(GO:0051775) |
| 0.2 | 1.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.2 | 2.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.2 | 1.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 2.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 | 1.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.2 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.2 | 1.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 | 0.2 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.2 | 1.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 1.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.2 | 5.9 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.2 | 1.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 | 0.2 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 | 5.4 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.2 | 0.9 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 0.5 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.2 | 0.9 | GO:0033622 | integrin activation(GO:0033622) |
| 0.2 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 0.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.2 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
| 0.2 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 2.3 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.2 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 | 0.3 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 0.2 | 10.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 6.4 | GO:0005977 | glycogen metabolic process(GO:0005977) |
| 0.2 | 1.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.2 | 0.9 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 1.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.2 | 1.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.2 | 0.5 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
| 0.2 | 1.4 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 0.6 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.1 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 0.4 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
| 0.1 | 2.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.4 | GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation(GO:0070145) |
| 0.1 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.4 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) |
| 0.1 | 0.3 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 1.6 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
| 0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 1.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 | 0.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 4.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.6 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
| 0.1 | 0.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 1.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 0.9 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 1.3 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 0.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 | 4.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 1.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 1.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 0.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 4.0 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
| 0.1 | 0.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 | 0.1 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.1 | 0.4 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.1 | 2.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 1.7 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 0.3 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) negative regulation of prostaglandin biosynthetic process(GO:0031393) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.1 | 0.4 | GO:0035573 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 | 1.0 | GO:0007129 | synapsis(GO:0007129) |
| 0.1 | 0.4 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 | 1.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.1 | 1.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 13.2 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.1 | 2.2 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.1 | 2.1 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 1.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.5 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.1 | 3.3 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 | 0.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.1 | 1.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 | 3.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.1 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.1 | 0.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 | 0.7 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 1.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.1 | 0.4 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.1 | 0.9 | GO:0071025 | RNA surveillance(GO:0071025) |
| 0.1 | 0.3 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.1 | 0.8 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.1 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 2.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.1 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 | 0.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.1 | 0.6 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 1.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 1.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.4 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.1 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.6 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 0.1 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.1 | 0.7 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 1.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.2 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 | 0.4 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation by host of symbiont transcription(GO:0052472) |
| 0.1 | 0.1 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.1 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.1 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.6 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 | 0.4 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 | 2.3 | GO:0007099 | centriole replication(GO:0007099) |
| 0.1 | 1.3 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 0.2 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.1 | 4.0 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
| 0.1 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 2.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 2.8 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 0.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.1 | 0.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 8.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 | 0.6 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 1.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 0.1 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 | 1.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.3 | GO:0042946 | glucoside transport(GO:0042946) |
| 0.1 | 0.6 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 4.0 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 0.2 | GO:0032258 | CVT pathway(GO:0032258) |
| 0.1 | 0.5 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 | 2.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 0.5 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 2.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
| 0.1 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.1 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.1 | 1.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 8.2 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.1 | 0.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 | 1.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.1 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 0.9 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 0.5 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 | 1.8 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 1.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.1 | 11.9 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.3 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.1 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.1 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 1.4 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 1.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.1 | 1.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.1 | 1.0 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
| 0.1 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 | 1.1 | GO:1902035 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.1 | GO:1902739 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 | 3.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.4 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 | 0.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.1 | 1.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 0.5 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
| 0.1 | 0.5 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 1.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 0.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.1 | 0.7 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 3.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.1 | 0.4 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
| 0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.1 | 0.9 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.1 | 4.1 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 | 0.1 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.1 | 4.5 | GO:0015908 | fatty acid transport(GO:0015908) |
| 0.1 | 0.5 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.1 | 0.1 | GO:0060876 | semicircular canal formation(GO:0060876) |
| 0.1 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 1.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 5.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.1 | 0.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 | 7.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.1 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 1.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 | 5.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 2.3 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 | 0.2 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
| 0.1 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.1 | 0.9 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.7 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 0.1 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.1 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 1.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 3.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 | 0.9 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 | 0.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 1.6 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 0.3 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.3 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.1 | 0.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.1 | 0.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.1 | 0.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.1 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 0.3 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.1 | 0.2 | GO:1904749 | positive regulation of telomeric DNA binding(GO:1904744) regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 | 0.2 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 0.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 3.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.1 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
| 0.1 | 1.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 2.4 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.1 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 | 1.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 1.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 0.2 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 1.7 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 3.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.1 | 0.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 | 0.2 | GO:1904353 | regulation of telomere capping(GO:1904353) |
| 0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 1.8 | GO:0097435 | fibril organization(GO:0097435) |
| 0.1 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.1 | 1.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.1 | 0.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.1 | 1.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 2.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 1.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.2 | GO:0000393 | generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 1.2 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
| 0.1 | 1.8 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.1 | 0.4 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 | 0.3 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.1 | 1.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.9 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.2 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.1 | 0.4 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.1 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 0.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.1 | 0.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 | 2.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 4.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.1 | 0.3 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.1 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.1 | 13.0 | GO:0007517 | muscle organ development(GO:0007517) |
| 0.1 | 1.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
| 0.1 | 0.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.1 | 0.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.1 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.1 | 1.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.1 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.1 | 0.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.1 | 0.4 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 2.5 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
| 0.1 | 0.7 | GO:0015893 | drug transport(GO:0015893) |
| 0.1 | 1.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.1 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.1 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.1 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.1 | 1.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.1 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.2 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 0.1 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 | 0.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.1 | 0.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 1.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 1.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.1 | 0.3 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 | 0.3 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 | 0.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.2 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
| 0.1 | 0.1 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 0.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 | 0.4 | GO:0036258 | multivesicular body assembly(GO:0036258) |
| 0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.0 | 0.2 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 | 0.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.0 | 0.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.0 | 1.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.0 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 | 0.8 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.5 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.1 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.3 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
| 0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.0 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.0 | 2.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.0 | 1.1 | GO:0051147 | regulation of muscle cell differentiation(GO:0051147) |
| 0.0 | 0.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
| 0.0 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 1.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 1.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
| 0.0 | 0.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.0 | 1.2 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 | 0.1 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.0 | 0.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 0.2 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
| 0.0 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 6.0 | GO:0032259 | methylation(GO:0032259) |
| 0.0 | 0.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 | 0.4 | GO:0034695 | response to prostaglandin E(GO:0034695) |
| 0.0 | 0.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 | 0.0 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.0 | 16.0 | GO:0007283 | spermatogenesis(GO:0007283) |
| 0.0 | 2.3 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.3 | GO:0006476 | protein deacetylation(GO:0006476) |
| 0.0 | 0.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.0 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 | 0.1 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
| 0.0 | 1.4 | GO:0001890 | placenta development(GO:0001890) |
| 0.0 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) regulation of opsonization(GO:1903027) |
| 0.0 | 0.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 | 0.4 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
| 0.0 | 0.1 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.0 | 0.3 | GO:0017145 | stem cell division(GO:0017145) |
| 0.0 | 0.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.0 | 0.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.0 | 0.1 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
| 0.0 | 0.1 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
| 0.0 | 0.3 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.0 | 0.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.0 | 1.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.0 | 2.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
| 0.0 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 0.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.0 | 0.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) cellular response to interleukin-2(GO:0071352) |
| 0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 | 0.3 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
| 0.0 | 0.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.0 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 | 0.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 0.0 | 0.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.0 | 0.1 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.0 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.0 | 0.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.0 | 0.1 | GO:2000329 | peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 2.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 | 0.5 | GO:0001823 | mesonephros development(GO:0001823) |
| 0.0 | 0.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
| 0.0 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.0 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.0 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 | 0.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 | 0.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.0 | 0.5 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.0 | 0.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 0.0 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.0 | 0.5 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 | 0.3 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 | 0.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 | 0.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.1 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 | 0.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.0 | 1.8 | GO:0006260 | DNA replication(GO:0006260) |
| 0.0 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.0 | 0.2 | GO:0019827 | stem cell population maintenance(GO:0019827) |
| 0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 0.0 | 0.4 | GO:0030509 | BMP signaling pathway(GO:0030509) |
| 0.0 | 0.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.0 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.0 | 0.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.0 | 0.0 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
| 0.0 | 0.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.0 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.0 | 0.0 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 46.6 | GO:0005861 | troponin complex(GO:0005861) |
| 2.2 | 11.0 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.8 | 5.5 | GO:0060987 | lipid tube(GO:0060987) |
| 1.7 | 5.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 1.7 | 5.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.6 | 4.8 | GO:0030689 | Noc complex(GO:0030689) |
| 1.5 | 4.4 | GO:0005914 | spot adherens junction(GO:0005914) |
| 1.4 | 14.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.4 | 5.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.3 | 1.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 1.3 | 1.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 1.3 | 9.1 | GO:1990393 | 3M complex(GO:1990393) |
| 1.3 | 5.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 1.2 | 3.7 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 1.2 | 7.3 | GO:0032449 | CBM complex(GO:0032449) |
| 1.2 | 1.2 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 1.2 | 8.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 1.1 | 3.4 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 1.1 | 5.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 1.0 | 7.0 | GO:0031523 | Myb complex(GO:0031523) |
| 1.0 | 1.0 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 1.0 | 2.9 | GO:1990923 | PET complex(GO:1990923) |
| 1.0 | 6.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.9 | 15.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.9 | 5.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.8 | 2.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.8 | 4.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.8 | 5.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.8 | 2.4 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.8 | 1.5 | GO:0032797 | SMN complex(GO:0032797) |
| 0.8 | 3.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.8 | 3.8 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.7 | 0.7 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.7 | 2.2 | GO:0044753 | amphisome(GO:0044753) |
| 0.7 | 3.6 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.7 | 2.1 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.7 | 3.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.7 | 2.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.7 | 4.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.7 | 2.7 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.7 | 11.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.7 | 2.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.7 | 5.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.6 | 2.6 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.6 | 3.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.6 | 8.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.6 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.6 | 2.4 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.6 | 3.6 | GO:1990357 | terminal web(GO:1990357) |
| 0.6 | 4.8 | GO:0071546 | pi-body(GO:0071546) |
| 0.6 | 6.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.6 | 3.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.6 | 3.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.6 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.5 | 1.6 | GO:0034657 | GID complex(GO:0034657) |
| 0.5 | 0.5 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.5 | 7.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.5 | 2.7 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.5 | 2.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.5 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.5 | 3.8 | GO:0034448 | EGO complex(GO:0034448) |
| 0.5 | 2.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.5 | 2.1 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.5 | 10.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.5 | 2.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.5 | 2.1 | GO:0071920 | cleavage body(GO:0071920) |
| 0.5 | 2.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.5 | 6.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.5 | 11.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.5 | 6.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.5 | 3.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.5 | 2.1 | GO:0044393 | microspike(GO:0044393) |
| 0.5 | 7.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.5 | 5.6 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.5 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.5 | 5.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.5 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.5 | 1.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.5 | 4.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.5 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
| 0.5 | 5.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.5 | 0.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.5 | 2.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.5 | 3.4 | GO:0071942 | XPC complex(GO:0071942) |
| 0.5 | 6.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.5 | 1.4 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.5 | 6.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.5 | 6.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.5 | 6.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.5 | 1.4 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.5 | 1.4 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.5 | 0.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.5 | 17.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.5 | 3.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.5 | 3.7 | GO:0032021 | NELF complex(GO:0032021) |
| 0.5 | 3.2 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.5 | 4.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.5 | 3.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.4 | 1.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.4 | 0.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.4 | 1.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.4 | 6.9 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.4 | 6.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 0.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.4 | 3.9 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.4 | 5.9 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.4 | 0.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.4 | 2.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.4 | 5.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.4 | 3.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.4 | 6.3 | GO:0034464 | BBSome(GO:0034464) |
| 0.4 | 4.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.4 | 3.7 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.4 | 2.4 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.4 | 4.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.4 | 4.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.4 | 7.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.4 | 1.6 | GO:0036028 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.4 | 9.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.4 | 2.4 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.4 | 2.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.4 | 3.6 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.4 | 2.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.4 | 5.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.4 | 65.2 | GO:0005604 | basement membrane(GO:0005604) |
| 0.4 | 15.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.4 | 3.1 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.4 | 1.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.4 | 4.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.4 | 2.3 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.4 | 8.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.4 | 4.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.4 | 1.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.4 | 1.1 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.4 | 1.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.4 | 4.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.4 | 2.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.4 | 2.2 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.4 | 6.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.4 | 41.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.4 | 1.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.4 | 11.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.4 | 1.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.4 | 4.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.4 | 2.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.4 | 1.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.4 | 2.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.4 | 6.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.4 | 1.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.4 | 3.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 6.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.4 | 6.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.4 | 14.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.4 | 12.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.3 | 1.7 | GO:0033503 | HULC complex(GO:0033503) |
| 0.3 | 3.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.3 | 2.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.3 | 2.8 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 7.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 5.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 1.0 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.3 | 7.8 | GO:0032982 | myosin filament(GO:0032982) |
| 0.3 | 2.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.3 | 1.0 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 2.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 4.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.3 | 1.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.3 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.3 | 1.0 | GO:0001534 | radial spoke(GO:0001534) |
| 0.3 | 25.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.3 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 0.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.3 | 1.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.3 | 1.6 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.3 | 1.6 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.3 | 2.6 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.3 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.3 | 2.5 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.3 | 5.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 1.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.3 | 0.6 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
| 0.3 | 4.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.3 | 1.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.3 | 4.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.3 | 0.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.3 | 1.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.3 | 6.9 | GO:0043034 | costamere(GO:0043034) |
| 0.3 | 1.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.3 | 5.7 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.3 | 5.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 1.5 | GO:0035363 | histone locus body(GO:0035363) |
| 0.3 | 5.3 | GO:0042555 | MCM complex(GO:0042555) |
| 0.3 | 1.5 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.3 | 0.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.3 | 1.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.3 | 2.6 | GO:0000938 | GARP complex(GO:0000938) |
| 0.3 | 3.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.3 | 0.9 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.3 | 2.3 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.3 | 0.9 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.3 | 1.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 3.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 2.5 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.3 | 3.4 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
| 0.3 | 2.0 | GO:0001652 | granular component(GO:0001652) |
| 0.3 | 2.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.3 | 2.2 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.3 | 3.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.3 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 1.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 4.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.3 | 3.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.3 | 3.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 3.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.3 | 18.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 10.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.3 | 5.1 | GO:0038201 | TOR complex(GO:0038201) |
| 0.3 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.3 | 0.8 | GO:0031251 | PAN complex(GO:0031251) |
| 0.3 | 1.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.3 | 2.4 | GO:0010369 | chromocenter(GO:0010369) |
| 0.3 | 3.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 1.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.3 | 8.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.3 | 1.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 0.8 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.3 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
| 0.3 | 0.3 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.3 | 2.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.3 | 5.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.3 | 2.0 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 2.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.3 | 3.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.3 | 2.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.3 | 4.3 | GO:0071203 | WASH complex(GO:0071203) |
| 0.3 | 6.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.3 | 9.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 23.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.2 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.2 | 5.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 4.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.2 | 4.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 1.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.2 | 18.8 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 4.4 | GO:0000776 | kinetochore(GO:0000776) |
| 0.2 | 3.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 2.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.2 | 4.3 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 0.5 | GO:0071010 | prespliceosome(GO:0071010) |
| 0.2 | 0.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.2 | 16.7 | GO:0005844 | polysome(GO:0005844) |
| 0.2 | 0.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.2 | 0.7 | GO:0032116 | SMC loading complex(GO:0032116) |
| 0.2 | 4.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.2 | 0.7 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.2 | 0.9 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.2 | 1.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.2 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 14.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.2 | 2.6 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.2 | 3.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 0.9 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 1.9 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
| 0.2 | 1.6 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.2 | 1.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 1.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.2 | 7.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 3.7 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 1.8 | GO:0045120 | pronucleus(GO:0045120) |
| 0.2 | 2.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 4.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.2 | 4.1 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 0.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 7.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.2 | 2.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 1.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 16.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.2 | 4.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.2 | 5.5 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.2 | 12.5 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 1.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.2 | 6.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 16.1 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 1.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 3.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.2 | 1.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 4.8 | GO:0000786 | nucleosome(GO:0000786) |
| 0.2 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 1.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.2 | 6.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.2 | 3.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.2 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.2 | 3.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.2 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 3.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 21.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.2 | 2.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 3.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 29.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.2 | 2.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.2 | 3.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
| 0.2 | 10.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.2 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 1.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 10.1 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.2 | 2.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.2 | 2.9 | GO:0001741 | XY body(GO:0001741) |
| 0.2 | 1.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.2 | 1.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.2 | 1.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 1.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 1.9 | GO:0030684 | preribosome(GO:0030684) |
| 0.2 | 3.2 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 2.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 20.1 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 9.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.2 | 1.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.2 | 2.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.2 | 2.4 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.2 | 21.6 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 1.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 3.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 0.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.2 | 2.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.2 | 4.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 12.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 31.5 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.2 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 8.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.2 | 0.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.2 | 2.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 29.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.2 | 1.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.2 | 104.7 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.2 | 1.0 | GO:0005694 | chromosome(GO:0005694) |
| 0.2 | 0.5 | GO:0008623 | CHRAC(GO:0008623) |
| 0.2 | 4.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 0.5 | GO:1990435 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
| 0.2 | 6.6 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 0.5 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
| 0.2 | 2.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 3.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 0.5 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.2 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 4.9 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.2 | 2.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.2 | 2.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.2 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 12.6 | GO:0005840 | ribosome(GO:0005840) |
| 0.2 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 1.1 | GO:0060091 | kinocilium(GO:0060091) |
| 0.2 | 44.5 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.2 | 0.8 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.2 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.2 | 0.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 1.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 2.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 2.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.1 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 3.2 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 1.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 1.9 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 3.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 18.1 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 0.7 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
| 0.1 | 0.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 0.4 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.1 | 3.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 0.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 1.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.1 | 1.0 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.1 | 3.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 6.0 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 0.4 | GO:0090651 | apical cytoplasm(GO:0090651) |
| 0.1 | 6.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 4.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 12.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 2.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.1 | 2.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 3.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 1.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 9.8 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 5.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 1.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 4.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 10.7 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 28.6 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.1 | 2.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.4 | GO:1990038 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 1.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 4.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 19.6 | GO:0031674 | I band(GO:0031674) |
| 0.1 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 1.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 2.9 | GO:0030016 | myofibril(GO:0030016) |
| 0.1 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
| 0.1 | 71.5 | GO:0016604 | nuclear body(GO:0016604) |
| 0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 53.7 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 3.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 1.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 0.6 | GO:0036452 | ESCRT-0 complex(GO:0033565) ESCRT complex(GO:0036452) |
| 0.1 | 4.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 9.4 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 1.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 1.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 0.6 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.1 | 10.0 | GO:0031514 | motile cilium(GO:0031514) |
| 0.1 | 2.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.1 | 9.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.3 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.1 | 22.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 1.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 2.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 7.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 34.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 1.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 4.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 0.5 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.1 | 4.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.3 | GO:0005816 | spindle pole body(GO:0005816) |
| 0.1 | 4.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 3.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 180.6 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.1 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 5.0 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 2.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 0.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 3.4 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.0 | 0.2 | GO:0097196 | Shu complex(GO:0097196) |
| 0.0 | 0.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.0 | 1.0 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.0 | 226.2 | GO:0005634 | nucleus(GO:0005634) |
| 0.0 | 0.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.0 | 1.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.0 | 0.1 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.0 | 2.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 1.0 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.0 | 3.7 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 0.0 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.0 | 1.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 1.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.0 | 0.1 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.8 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.0 | 0.0 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.0 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.0 | 5.4 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 0.0 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 4.1 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.0 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 0.0 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.3 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.0 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 7.6 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 2.3 | 32.5 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.9 | 7.5 | GO:0034584 | piRNA binding(GO:0034584) |
| 1.8 | 5.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 1.8 | 7.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.8 | 5.3 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 1.6 | 4.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 1.5 | 7.6 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.5 | 1.5 | GO:0043398 | HLH domain binding(GO:0043398) |
| 1.4 | 7.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.4 | 5.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.3 | 10.6 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 1.3 | 3.9 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.3 | 5.2 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 1.2 | 10.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.2 | 3.7 | GO:0004314 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 1.2 | 3.7 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 1.2 | 3.7 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 1.2 | 3.6 | GO:0046715 | borate transmembrane transporter activity(GO:0046715) |
| 1.2 | 9.4 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.2 | 3.5 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 1.2 | 3.5 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 1.1 | 3.4 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 1.1 | 2.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.1 | 7.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.1 | 11.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 1.0 | 7.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.0 | 3.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 1.0 | 4.1 | GO:0030172 | troponin C binding(GO:0030172) |
| 1.0 | 8.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 1.0 | 9.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.0 | 6.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 1.0 | 2.9 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 1.0 | 4.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.0 | 6.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.9 | 2.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.9 | 3.7 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.9 | 7.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.9 | 3.7 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.9 | 8.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.9 | 12.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.9 | 4.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.9 | 4.5 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.9 | 2.7 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.9 | 2.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.9 | 0.9 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.9 | 0.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.9 | 4.4 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.9 | 4.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.9 | 2.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.9 | 9.5 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.9 | 2.6 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.8 | 2.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.8 | 3.4 | GO:0005287 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 0.8 | 2.5 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.8 | 4.2 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.8 | 2.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.8 | 4.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.8 | 16.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.8 | 6.5 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.8 | 3.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.8 | 0.8 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.8 | 4.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.8 | 2.4 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.8 | 2.4 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.8 | 0.8 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.8 | 4.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.8 | 2.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.8 | 0.8 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
| 0.8 | 7.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.8 | 26.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.8 | 10.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.8 | 5.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.8 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.8 | 2.3 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.8 | 5.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.8 | 2.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.7 | 5.2 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.7 | 6.0 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.7 | 2.2 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.7 | 6.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.7 | 3.6 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.7 | 7.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.7 | 4.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.7 | 15.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.7 | 3.5 | GO:0004803 | transposase activity(GO:0004803) |
| 0.7 | 1.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.7 | 4.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.7 | 10.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.7 | 6.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.7 | 2.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.7 | 2.0 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.7 | 2.0 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.7 | 2.7 | GO:0030395 | lactose binding(GO:0030395) |
| 0.7 | 3.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.7 | 2.6 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.7 | 2.6 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 0.7 | 2.6 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.7 | 2.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.7 | 3.9 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.7 | 2.0 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 0.7 | 18.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.6 | 1.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.6 | 5.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.6 | 1.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.6 | 7.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.6 | 5.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.6 | 3.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.6 | 4.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.6 | 3.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.6 | 1.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.6 | 1.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.6 | 4.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.6 | 3.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.6 | 1.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.6 | 3.6 | GO:0004096 | catalase activity(GO:0004096) |
| 0.6 | 4.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.6 | 1.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.6 | 6.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.6 | 4.2 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.6 | 3.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.6 | 3.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.6 | 9.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.6 | 3.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.6 | 5.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.6 | 3.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.6 | 15.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.6 | 1.8 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.6 | 2.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.6 | 2.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.6 | 3.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.6 | 12.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.6 | 1.7 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.6 | 1.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.6 | 6.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.6 | 1.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.6 | 2.9 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.6 | 0.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.6 | 2.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.6 | 1.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.6 | 2.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.6 | 15.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.6 | 3.9 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.6 | 8.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.6 | 1.7 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.6 | 2.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.6 | 1.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.6 | 5.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.6 | 1.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.6 | 1.7 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 0.6 | 1.7 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.5 | 3.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.5 | 3.8 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.5 | 6.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.5 | 2.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.5 | 1.6 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 0.5 | 9.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.5 | 3.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.5 | 1.6 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.5 | 1.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.5 | 6.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.5 | 3.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.5 | 1.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.5 | 1.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.5 | 2.1 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.5 | 3.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.5 | 6.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.5 | 1.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.5 | 3.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.5 | 1.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.5 | 2.6 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.5 | 1.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.5 | 4.7 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.5 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.5 | 3.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.5 | 4.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.5 | 2.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.5 | 2.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.5 | 4.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.5 | 0.5 | GO:0032407 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
| 0.5 | 2.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.5 | 1.5 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.5 | 5.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.5 | 5.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.5 | 4.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.5 | 14.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.5 | 4.5 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.5 | 3.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.5 | 2.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.5 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.5 | 3.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.5 | 1.5 | GO:0035473 | lipase binding(GO:0035473) |
| 0.5 | 2.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.5 | 3.0 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.5 | 8.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.5 | 1.5 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.5 | 4.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.5 | 3.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.5 | 3.4 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.5 | 1.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.5 | 4.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.5 | 3.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.5 | 2.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.5 | 1.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.5 | 1.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.5 | 2.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.5 | 1.4 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.5 | 3.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.5 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.5 | 3.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.5 | 1.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.5 | 2.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.5 | 3.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.5 | 2.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.5 | 1.9 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.5 | 3.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.5 | 1.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.5 | 3.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.5 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.5 | 2.7 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.5 | 15.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.5 | 8.6 | GO:0048185 | activin binding(GO:0048185) |
| 0.5 | 2.3 | GO:0036122 | BMP binding(GO:0036122) |
| 0.4 | 3.1 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.4 | 50.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.4 | 1.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.4 | 4.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.4 | 4.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.4 | 2.2 | GO:0070905 | serine binding(GO:0070905) |
| 0.4 | 1.3 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.4 | 0.9 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.4 | 3.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.4 | 2.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.4 | 9.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.4 | 2.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.4 | 2.2 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.4 | 0.4 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.4 | 0.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.4 | 58.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.4 | 3.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.4 | 4.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 3.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.4 | 1.7 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.4 | 3.0 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.4 | 1.3 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.4 | 1.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.4 | 1.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.4 | 1.3 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.4 | 2.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.4 | 1.7 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.4 | 10.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.4 | 2.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.4 | 14.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.4 | 2.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.4 | 1.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.4 | 2.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.4 | 2.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.4 | 1.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.4 | 5.3 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.4 | 5.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.4 | 8.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.4 | 2.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 1.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.4 | 1.2 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.4 | 3.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.4 | 0.4 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 0.4 | 1.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.4 | 1.6 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.4 | 3.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.4 | 3.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.4 | 1.2 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.4 | 8.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.4 | 3.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.4 | 1.2 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.4 | 1.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.4 | 2.3 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.4 | 5.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.4 | 11.8 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 1.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.4 | 6.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.4 | 2.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.4 | 1.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
| 0.4 | 1.5 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.4 | 1.1 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.4 | 1.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.4 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 7.5 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.4 | 1.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.4 | 10.9 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.4 | 1.9 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.4 | 0.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.4 | 4.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.4 | 2.6 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.4 | 13.5 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.4 | 1.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.4 | 2.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.4 | 1.4 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 0.4 | 1.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.4 | 4.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.4 | 2.5 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.4 | 1.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.4 | 1.4 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
| 0.4 | 4.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 0.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.4 | 3.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.4 | 23.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.4 | 1.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.4 | 1.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.4 | 5.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 3.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.3 | 9.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.3 | 2.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.3 | 7.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 6.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 0.3 | GO:0016436 | rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (uridine) methyltransferase activity(GO:0016436) |
| 0.3 | 7.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.3 | 3.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 1.4 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.3 | 3.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.3 | 3.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.3 | 2.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.3 | 1.0 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.3 | 1.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.3 | 1.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.3 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.3 | 3.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.3 | 1.0 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.3 | 3.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.3 | 1.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 2.3 | GO:0042806 | fucose binding(GO:0042806) |
| 0.3 | 5.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.3 | 1.0 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.3 | 1.0 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 0.3 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.3 | 2.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.3 | 1.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.3 | 3.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.3 | 3.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.3 | 1.0 | GO:0090422 | thiamine pyrophosphate transporter activity(GO:0090422) |
| 0.3 | 1.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 2.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.3 | 14.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 0.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) activin receptor binding(GO:0070697) |
| 0.3 | 31.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
| 0.3 | 2.5 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.3 | 1.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.3 | 2.5 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.3 | 1.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.3 | 5.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 1.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.3 | 1.6 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.3 | 2.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.3 | 6.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 8.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.3 | 4.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 1.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 0.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.3 | 1.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.3 | 1.2 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.3 | 0.3 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.3 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.3 | 10.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.3 | 3.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.3 | 0.9 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.3 | 1.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.3 | 0.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.3 | 5.9 | GO:0005537 | mannose binding(GO:0005537) |
| 0.3 | 1.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.3 | 4.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 1.8 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.3 | 3.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.3 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.3 | 8.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 12.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.3 | 1.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.3 | 2.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.3 | 1.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.3 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 2.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.3 | 1.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.3 | 4.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.3 | 1.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 2.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.3 | 0.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.3 | 0.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.3 | 3.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.3 | 1.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.3 | 0.8 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.3 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.3 | 0.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.3 | 7.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 5.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.3 | 3.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.3 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.3 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.3 | 1.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.3 | 5.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.3 | 8.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.3 | 1.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.3 | 1.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.3 | 3.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.3 | 4.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.3 | 0.8 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.3 | 0.8 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.3 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 27.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.3 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 0.8 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.3 | 2.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.3 | 4.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.3 | 1.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.3 | 4.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.3 | 2.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.3 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.3 | 6.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.3 | 1.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.3 | 1.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.3 | 3.5 | GO:0004386 | helicase activity(GO:0004386) |
| 0.3 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 3.5 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.3 | 1.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.3 | 9.0 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.2 | 1.7 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.2 | 1.2 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 1.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 1.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 0.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
| 0.2 | 5.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.2 | 15.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.2 | 10.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.2 | 10.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 1.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 1.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 1.0 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.2 | 5.5 | GO:0005536 | glucose binding(GO:0005536) |
| 0.2 | 4.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 4.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 1.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 1.2 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.2 | 0.7 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.2 | 0.2 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 0.2 | 2.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 23.8 | GO:0005518 | collagen binding(GO:0005518) |
| 0.2 | 3.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 2.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.2 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.2 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.2 | 1.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.2 | 4.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 0.7 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.2 | 0.7 | GO:0004411 | homogentisate 1,2-dioxygenase activity(GO:0004411) |
| 0.2 | 3.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.2 | 2.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 1.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 3.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.2 | 4.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 1.1 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.2 | 3.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 0.7 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.2 | 14.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.2 | 2.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.2 | 0.9 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.2 | 1.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.2 | 14.0 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 5.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 2.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 3.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.2 | 1.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 1.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.2 | 8.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.2 | 6.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.2 | 19.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.2 | 0.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.2 | 1.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.2 | 0.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.2 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.2 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 0.6 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.2 | 3.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.2 | 0.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 1.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 2.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.2 | 5.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.2 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 6.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.2 | 0.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.2 | 3.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.2 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 2.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.2 | 0.6 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.2 | 1.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 2.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.2 | 5.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 3.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 10.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.2 | 0.6 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 15.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 0.4 | GO:0000035 | acyl binding(GO:0000035) |
| 0.2 | 20.0 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.2 | 5.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.2 | 5.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 1.0 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.2 | 1.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 13.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.2 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.6 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.2 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 2.7 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 1.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.2 | 1.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 2.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 0.4 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.2 | 6.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.2 | 0.7 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.2 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.2 | 1.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.2 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.2 | 0.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.2 | 1.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.2 | 8.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 1.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.2 | 3.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 0.9 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 0.2 | 5.7 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.2 | 0.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 1.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 6.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.2 | 3.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 1.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 2.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.2 | 2.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 5.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.2 | 0.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 0.2 | 34.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 2.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 7.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 1.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
| 0.2 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.2 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 1.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.2 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.2 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 5.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 1.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.2 | 2.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 0.5 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.2 | 4.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 2.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.2 | 6.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.2 | 0.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.2 | 0.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.2 | 1.8 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.2 | 3.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.2 | 2.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.2 | 15.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.2 | 0.5 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.2 | 1.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 4.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 1.6 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 4.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 2.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.2 | 0.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.2 | 0.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.2 | 0.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 0.3 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.2 | 1.1 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.2 | 14.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.2 | 3.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 8.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.2 | 0.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 6.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 0.9 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.2 | 3.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.2 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.2 | 0.2 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.2 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.2 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 12.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.2 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.2 | 2.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.2 | 2.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 2.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 2.8 | GO:0055103 | ligase regulator activity(GO:0055103) |
| 0.1 | 0.4 | GO:0050560 | aspartate-tRNA ligase activity(GO:0004815) aspartate-tRNA(Asn) ligase activity(GO:0050560) |
| 0.1 | 0.4 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.1 | 1.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 2.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.6 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.1 | 2.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 1.2 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 2.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 1.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 1.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 23.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 14.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.4 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.1 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 3.5 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.1 | 0.3 | GO:0032557 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
| 0.1 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.1 | 0.7 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.1 | 0.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 438.2 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 2.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.1 | 5.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 1.6 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.1 | 1.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 4.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 0.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 2.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.5 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.4 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.1 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 0.3 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.1 | 19.7 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 2.9 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 0.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 2.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.6 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 0.7 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.1 | 0.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 13.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 0.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.1 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.1 | 1.4 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 0.3 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 1.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.1 | 4.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 3.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 0.1 | GO:0004040 | amidase activity(GO:0004040) |
| 0.1 | 1.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.4 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 2.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 6.0 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 1.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 2.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.1 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 0.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.1 | 0.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.1 | 0.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.1 | 8.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.5 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.1 | 2.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.1 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 3.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.4 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.1 | 0.3 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 0.5 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.1 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 130.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
| 0.1 | 2.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 15.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.1 | 2.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 2.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 23.8 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 5.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.1 | 0.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.1 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 8.9 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 1.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 1.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 1.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 1.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.4 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.1 | 2.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 1.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 9.6 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.1 | 0.2 | GO:0070975 | FHA domain binding(GO:0070975) |
| 0.1 | 4.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 0.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 3.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 1.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.1 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.1 | 1.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.1 | 0.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.1 | 0.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
| 0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 1.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.1 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 0.2 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.1 | 0.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.1 | 0.8 | GO:0004519 | endonuclease activity(GO:0004519) |
| 0.1 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 1.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.4 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 0.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.0 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 0.7 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.0 | 1.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.0 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.0 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.0 | 24.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.0 | 0.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.1 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.0 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.0 | 0.6 | GO:0009975 | cyclase activity(GO:0009975) |
| 0.0 | 0.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.0 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.0 | 0.1 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.0 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.0 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.0 | 4.8 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 0.1 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.1 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.0 | 0.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 10.4 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.0 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.0 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 2.1 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 2.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.0 | 0.1 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.0 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.0 | 0.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.0 | 1.0 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.0 | 0.4 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 0.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 2.1 | 4.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 1.0 | 1.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.9 | 67.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.7 | 13.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.7 | 26.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.5 | 37.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.5 | 26.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.4 | 1.8 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.4 | 16.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 32.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.4 | 3.1 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.4 | 11.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.4 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.4 | 110.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.4 | 16.0 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.3 | 24.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.3 | 13.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.3 | 11.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 6.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 20.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.3 | 25.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.3 | 1.9 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.3 | 17.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.3 | 7.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 14.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.3 | 14.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.3 | 4.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 24.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.3 | 1.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.3 | 11.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 4.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.2 | 4.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 10.1 | PID MYC PATHWAY | C-MYC pathway |
| 0.2 | 21.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.2 | 6.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 5.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 14.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 13.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 5.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 20.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.2 | 5.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 13.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 3.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 7.5 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 8.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.2 | 4.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.2 | 16.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 2.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.2 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 16.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 2.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 2.6 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 2.8 | PID ATM PATHWAY | ATM pathway |
| 0.2 | 4.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 7.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 1.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 16.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 3.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.2 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 3.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 12.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 52.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 7.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 7.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 1.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 9.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 3.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 2.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 6.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 5.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 1.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 6.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 4.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 3.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 3.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 7.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 20.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 3.9 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 2.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 3.8 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 3.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 10.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.0 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 76.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.9 | 25.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.9 | 0.9 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.7 | 13.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.7 | 18.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.7 | 8.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.6 | 66.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.6 | 11.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.6 | 15.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.6 | 19.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.5 | 13.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.5 | 9.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.5 | 1.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.5 | 21.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.5 | 3.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.5 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.4 | 6.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.4 | 9.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.4 | 8.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.4 | 1.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.4 | 6.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.4 | 17.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.4 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.4 | 13.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.4 | 6.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.4 | 17.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.4 | 14.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.4 | 7.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.4 | 22.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.4 | 6.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.3 | 20.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 12.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.3 | 7.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.3 | 7.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.3 | 7.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.3 | 2.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.3 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.3 | 7.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 1.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 6.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.3 | 1.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.3 | 6.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 7.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.3 | 8.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.3 | 10.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.3 | 16.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.3 | 7.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.3 | 9.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.3 | 2.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 7.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.3 | 5.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.3 | 35.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.3 | 8.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.3 | 10.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.3 | 3.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.3 | 5.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.3 | 2.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 1.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 7.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
| 0.3 | 4.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.2 | 13.8 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.2 | 10.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 12.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 2.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.2 | 3.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 0.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.2 | 3.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.2 | 6.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 3.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 8.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 11.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.2 | 5.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 0.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.2 | 6.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.2 | 9.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 3.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.2 | 3.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.2 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 4.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 6.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.2 | 33.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 2.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 2.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.2 | 0.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.2 | 15.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.2 | 20.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 2.9 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
| 0.2 | 3.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 72.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.2 | 13.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 2.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.2 | 9.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.2 | 1.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 3.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 14.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.2 | 5.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.2 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.2 | 0.9 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 1.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 10.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.2 | 4.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.2 | 3.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 5.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 6.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 3.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 2.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.2 | 4.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 4.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.2 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.2 | 7.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.2 | 3.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 6.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 1.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 3.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.1 | 4.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 10.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 6.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
| 0.1 | 10.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 3.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 2.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 1.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.1 | 2.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 2.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 2.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.1 | 1.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 3.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 15.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 1.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 2.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 2.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 3.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.1 | 3.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 1.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.1 | 4.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.1 | 18.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 1.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 11.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 5.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.1 | 2.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 3.3 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 3.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.8 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.1 | 1.2 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.1 | 2.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.0 | 5.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.0 | 4.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 1.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 2.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.0 | 2.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 1.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 0.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.0 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 0.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |